Meeting Agenda

ACTC 2012 TENTATIVE PROGRAM


Day 1

Day 2

Day 3

Day 4



DAY 3: Friday, September 28th, 2012

Time Session/Title Confirmed Speaker
Friday, Sept 28
8:30 – 12:00
Plenary Lecture Session 4:
CTCs as tumour biomarkers in breast cancer
8:30 – 9:00
PL4-1
“Hematogenous and lymphatic tumour cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast” Tanja Fehm,Professor, Department of Gynecology,University of Tuebingen, Germany
9:00 – 9:30
PL4-2
“HER2-Positive Circulating Tumour Cells in Breast Cancer” Michail Ignatiadis,Jules Bordet Institute, Brussels, Belgium
9:30 – 10:00
PL4-3
“Success study on CTC in the adjuvant setting” Wolfgang Janni,Professor, Universitätsklinikum Frauenklinik, Düsseldorf, Nordrhein-Westfalen, Germany
10:00 – 10:30
PL4-4
“Disseminated Tumour Cells in Breast Cancer Patients” Bjorn Naume,Radium Hospital, Oslo, Norway
10:30 – 11:00 Networking Coffee Break in the Exhibition Hall
11:00 – 11:30
PL4-5
“Clinical value of circulating endothelial cells and circulating tumour cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy” Jean-Yves Pierga,Institute Curie, Paris, France
11:30 – 12:00
PL4-6
TO BE ANNOUNCED Dimitris Mavroudis,
Professor, School of Medicine, University of Crete, Greece
12:00 – 13:00 Lunch Break - Exhibition visit
13:00 – 14:00 ORAL PRESENTATION 3 (Selected Oral Presentations (n=6 speakers, 10 min each plus time for questions)
  • O3-1
  • O3-2
  • O3-3
  • O3-4
  • O3-5
  • O3-6
14:00 – 15:30 POSTER SESSION 3
15:30 – 16:00 Networking Coffee Break in the Exhibition Hall
16:00 – 17:30
Drug Development Forum :


(Pharmaceutical Companies Sponsored Oral Presentations)
(n=3 Speakers, 30 min each)
17:30 – 18:30
EXPERT PANEL:
CTC and personalized medicine: Future challenges
Moderator:
Panelists:
20:00 GALA DINNER PARTY